Coronavirus: COVID-19 patients should also report adverse reactions

The European Medicines Agency (EMA) and the Federal Agency for Medicines and Health Products (FAMHP) would like to remind patients, particularly those with or suspected of having COVID-19, that they can report adverse effects believed to be associated with taking one or more medicinal products.

As a reminder, there is currently no medicinal product indicated for the treatment of COVID-19. In the fight against the novel coronavirus, doctors are using medicinal products that were initially developed to treat other pathologies (more information: what medicinal products are used in the fight against COVID-19?).

Understanding of the new COVID-19 virus remains incomplete, particularly regarding possible interactions between the medicinal products patients may take to treat it.

The information provided in the reports made by patients and healthcare professionals, who continue to report adverse reactions during the pandemic, will add to the knowledge currently gained through clinical studies. This will allow decisions to be made about the safe and effective use of medicinal products as the pandemic further develops. Report adverse effects.

If they wish, patients can also report the effects encountered to their doctor, nurse or pharmacist who can then report these adverse effects via the system for health professionals.

In all cases, patients are advised to always contact their doctor, nurse or pharmacist if they are concerned about a suspected adverse reaction to a medicinal product.

Last updated on
07/05/2020